Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | PTPRC | P08575 | 1/20 | 0.40 |
| ▸ | S100A4 | P26447 | 1/20 | 0.40 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10477945 | 0.81 | CYP1A2 (0.54) | CYP1A2TSHRALDH1A1TDP1HSD17B10 | |
| SCHEMBL31207336 | 0.80 | CYP1A2 (0.53) | CYP1A2TSHRALDH1A1TDP1HSD17B10 | |
| SCHEMBL7616610 | 0.80 | CYP1A2 (0.53) | CYP1A2TSHRALDH1A1TDP1HSD17B10 | |
| SCHEMBL3279320 | 0.79 | CYP1A2 (0.53) | CYP1A2TSHRALDH1A1TDP1HSD17B10 | |
| SCHEMBL10569743 | 0.79 | CYP1A2 (0.50) | CYP1A2TSHRALDH1A1TDP1HSD17B10 | |
| SCHEMBL5583438 | 0.78 | CYP1A2 (0.56) | CYP1A2TSHRALDH1A1TDP1HSD17B10 | |
| SCHEMBL4692662 | 0.78 | CYP1A2 (0.51) | CYP1A2TSHRALDH1A1TDP1HSD17B10 | |
| SCHEMBL31633570 | 0.78 | CYP1A2 (0.56) | CYP1A2TSHRALDH1A1TDP1HSD17B10 | |
| SCHEMBL4690726 | 0.78 | CYP1A2 (0.60) | CYP1A2TSHRALDH1A1TDP1HSD17B10 | |
| SCHEMBL16284293 | 0.78 | CYP1A2 (0.51) | CYP1A2TSHRALDH1A1TDP1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120272461-A1 | DYES WITH CHANGEABLE SOLUBILITIES, AND METHODS FOR THEIR USE | CRESTLINE DIRECT FINANCE, L.P. | 2012-11-01 | — | — | US | disclosed |
| US-20120272461-A1 | DYES WITH CHANGEABLE SOLUBILITIES, AND METHODS FOR THEIR USE | CRESTLINE DIRECT FINANCE, L.P. | 2012-11-01 | — | — | US | disclosed |
| US-20120272461-A1 | DYES WITH CHANGEABLE SOLUBILITIES, AND METHODS FOR THEIR USE | CRESTLINE DIRECT FINANCE, L.P. | 2012-11-01 | — | — | US | disclosed |
| US-8298298-B1 | Dyes with changeable solubilities, and methods for their use | Empire Development Technology LLC (US) | 2012-10-30 | — | — | US | disclosed |
| US-8298298-B1 | Dyes with changeable solubilities, and methods for their use | Empire Development Technology LLC (US) | 2012-10-30 | — | — | US | disclosed |
| US-8298298-B1 | Dyes with changeable solubilities, and methods for their use | Empire Development Technology LLC (US) | 2012-10-30 | — | — | US | disclosed |
| US-8246698-B2 | Dyes with changeable solubilities, and methods for their use | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2012-08-21 | — | — | US | disclosed |
| US-8246698-B2 | Dyes with changeable solubilities, and methods for their use | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2012-08-21 | — | — | US | disclosed |
| US-8246698-B2 | Dyes with changeable solubilities, and methods for their use | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2012-08-21 | — | — | US | disclosed |
| US-20120164288-A1 | DYES WITH CHANGEABLE SOLUBILITIES, AND METHODS FOR THEIR USE | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2012-06-28 | — | — | US | disclosed |
| US-20120164288-A1 | DYES WITH CHANGEABLE SOLUBILITIES, AND METHODS FOR THEIR USE | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2012-06-28 | — | — | US | disclosed |
| US-20120164288-A1 | DYES WITH CHANGEABLE SOLUBILITIES, AND METHODS FOR THEIR USE | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164288-A1 | DYES WITH CHANGEABLE SOLUBILITIES, AND METHODS FOR THEIR USE | STRA6, CDC73, CD44 | CYP1A2 3422/4885TSHR 3987/4885ALDH1A1 2416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.